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Cytoskeletal agents inhibit motility and adherence of human
tumor cells
MARY L. STRACKE, MEHRDAD SOROUSH, LANCE A. LIOTTA, and ELLIOTT SCHIFFMANN
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Cytoskeletal agents inhibit motility and adherence of human tumor
cells. Cytoskeletal agents have been demonstrated to inhibit stimulated
motility and substrate adherence by the human tumor cell line, A2058.
cis-tubulozole, taxol, and cytochalasin D were tested for their effects on
chemotaxis in response to a tumor cytokine, autocrine motility factor,
and on adherence to several substrata: laminin- and gelatin-coated
dishes as well as tissue culture plastic. Cytochalasin D, which inhibits
microfilament polymerization, abolished stimulated motility. Taxol,
which stabilizes microtubules, decreased stimulated motility to a
greater degree than cis-tubulozole, which inhibits microtubular poly-
merization. In contrast, cis-tubulozole had the greatest inhibitory effect
on adherence with a gelatin substratum more affected (100% inhibition)
than tissue culture plastic (90%) or laminin substratum (52%). Taxol
affected adherence in the same order but less than cis-tubulozole.
Cytochalasin D had no significant effect on adherence to laminin with
moderate inhibition of adherence to tissue culture plastic or gelatin.
These data suggest that, in these tumor cells, microfilaments are more
crucial for motility than adherence, but the dynamic polymerization and
depolymerization of microtubules are required for both types of cellular
activities.
Migration is an essential feature in the dissemination of
metastatic tumor cells throughout the host. Each time a metas-
tasizing tumor cell traverses a biological barrier such as a
basement membrane, there appear to be at least three necessary
stages of cellular function [1]: adherence to an extracellular
matrix, release of proteolytic enzymes, and the motile response
itself. It is probable that these stages occur concertedly as the
cell progresses.
Neutrophils [2] and fibroblasts [3] have been shown to require
activation of the cytoskeleton for locomotion. Pharmacologic
agents that act on cytoskeletal components have been tested
extensively for their effect on neutrophil and fibroblast locomo-
tion. Agents such as coichicine, which inhibits microtubular
polymerization, have been shown to inhibit motility in fibro-
blasts [4] and directional motility in polymorphonuclear leuko-
cytes [5]. Coichicine has also been shown to inhibit leading edge
migration and adherence to an endothelial monolayer by B16-
FlO murine melanoma cells [6]. Taxol, which stabilizes micro-
tubules, has been demonstrated to affect motility in a variety of
cells [7, 8]. The cytochalasins B and D, which inhibit actin
polymerization [9, 10], also abolish motility [11—13] in fibro-
blasts, neutrophils, and glioma cells, respectively.
In this report, we have employed the cis isomer of tubulozole
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which, like colchicine, inhibits microtubular polymerization
[14], taxol, and the cytochalasins B and D. Using the A2058
human melanoma cell line, we have studied the effects of these
agents upon motility stimulated by autotocrine motility factor
(AMF), a cytokine which these same cells synthesize [15, 16].
We have also measured their effect on adherence to laminin-
and gelatin-coated dishes as well as tissue culture plastic. We
wish to compare the effect of these pharmacologic agents in
tumor cells to the well-documented observations made in
neutrophils and fibroblasts. We also have attempted to utilize
these agents as tools in order to assess the relative contribution




The polycarbonate nucleopore membranes (8 sm pore size,
polyvinylpyrrolidone-free), the 48-well micro-chemotaxis
chambers, the 12-well manifold chamber, and the modified
Boyden chambers were obtained from Neuro-Probe, Inc. (Cab-
in John, Maryland, USA). The Immulon 1 Dynated Microfitter
System was purchased from Dynated Laboratories, Inc. (Chan-
tilly, Virginia, USA). Cis and trans isomers of tubulozole were
donated by Dr. M. Mareel (Dept. of Radiotherapy and Nuclear
Medicine, University Hospital, De Pintelaan 185, Gert, Bel-
gium). Taxol was provided by Dr. Matthew Suffness (Natural
Products Branch, Developmental Therapeutics Programs, Di-
vision of Cancer Treatment, Nd). Cytochalasin B and D were
purchased from Sigma Chemical Co. (St. Louis, Missouri,
USA).
Cell culture
The human melanoma cell line A2058, originally isolated by
Todaro, Fryling and DeLarco [17], was maintained as previ-
ously described [15].
Production of autocrine motility factor (AMF)
This was accomplished as before [18], except that Phenol
Red-free Dulbecco's Modified Eagle's medium (DMEM) was
used for production of the factor. The AMF preparation was
concentrated 25-fold at neutral pH using an Amicon ultra-
filtration assembly that retained species of Mr> 30,000. AMF
served as a positive control for stimulated motility.
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Cell motility assay
The assay used to determine cell motility was described
previously in detail [19]. Each pharmacologic agent was pre-
pared at 20 x the final concentration and then added at a 1:20
dilution to cell suspensions. The cells were incubated in the
presence of the drug for one hour at room temperature then
added to the upper wells of the micro-chemotaxis chamber
(100,000 cells/well). Cells were maintained in appropriate con-
centrations of the agents throughout the assay. All experiments
were performed in triplicate with both AMF (chemotactic
positive control) and 0.1% BSA-DMEM (unstimulated random
motility) added separately to the bottom wells for each concen-
tration of every agent. At the end of a four hour incubation at
37°C, filters were removed, fixed and stained with Diff-Quik
(Baxter Scientific, McGaw Park, Illinois, USA), then mounted
on glass slides. Cells that had migrated were quantitated by light
microscopy under high power field (HPF) at a magnification of
400x. Five randomly chosen HPF's were counted for each
replicate.
Reversibility of cytoskeletal agents
Cells were incubated at room temperature in the presence of
the cytoskeletal agents diluted in 0.1% BSA-DMEM for one
hour, centrifuged, and either washed twice with the same
dilution of drug or in 0,1% BSA-DMEM. The cells were then
allowed a 30-minute recovery period at room temperature prior
to the start of the chemotaxis assay. Untreated cells, which had
undergone similar incubations and centrifugations, were tested
concomitantly as controls.
Adherence to tissue culture plastic
Cells were treated with the cytoskeletal agents at appropriate
concentrations for one hour prior to the start of the assay as
well as throughout the assay. After the preincubation, 1 x 106
cells were added in triplicate to 12-well tissue culture plates.
After a 90 minute incubation at 37°C, the cells were washed
twice with Dulbecco's Phosphate Buffered Saline (DPBS) with-
out Ca or Mg + to remove non-adherent cells, and then
detached using 100 /l of trypsin-EDTA. The adherent cells
were quantitated in the presence of Trypan blue stain using a
hemocytometer.
Production of laminin
Laminin was purified from the Engelbreth-Holm-Swarm tu-
mor as described [20, 21], and its homogeneity was verified by
electrophoretic analysis.
Adherence to laminin or gelatin
Using a 96-well Immulon 1 Dynated Microfitter System, 3
sg/well of laminin or gelatin in a 0.05 ml volume of DPBS with
Ca and Mg was allowed to coat the wells overnight. The
wells were then washed three times with DPBS with Ca + and
Non-specific binding of cells to the plastic was blocked
by incubating the coated wells in 0.1% BSA in DMEM for 45
minutes. Cells which had been pretreated with cytoskeletal
agents for one hour were then added to the wells at 50,000 to
75,000 cells/well. Cells were maintained in appropriate concen-
trations of the agents throughout the assay. After a two hour
incubation at 37°C, the wells were washed twice with DPBS
without Ca + orMg and the cells were detached using 50 tl
trypsin-ethylenediaminetetraacetic acid. The cells were then
counted with a hemocytometer as described above.
Chemotaxis of pre-adherent cells
For the pre-adherence assays, we used a 12-well manifold
chamber which allows addition to and removal of material from
the bottom well during the course of an assay. We added
150,000 untreated cells to the top wells of the chamber and
allowed them to attach for one hour at 37°C with only 0.1%
BSA-DMEM present in the bottom wells. After attachment,
either AMF (chemotactic positive control) or 0.1% BSA-
DMEM (unstimulated random motility) was carefully added to
the lower wells so that the attached cells remained undisturbed
in the upper well. Cytoskeletal agents (10 M) were then added
to the cells in the upper wells. After a four hour incubation at
37°C the filters were removed, stained with Diff-Quik, and
mounted on glass slides. The migrated cells, in triplicate wells,
were counted by light microscopy as described above.
A regular chemotaxis assay was run concurrently in which
the cytoskeletal agent was added to the cells immediately prior
to placing them in the chamber. For this assay there was no
period of pre-attachment so that either AMF or 0.1% BSA-
DMEM was in the lower wells from the start of the assay. This
also was run for four hours, then was fixed, stained and counted
as described.
Results
Effect of cytoskeletal agents on motility
We employed the human melanoma cell line, A2058, as a
model for tumor cell motility and used its own autoctrine
motility factor (AMF) to induce the motile response [15, 16]. In
employing this model, cells were pretreated for one hour with
cytoskeletal agents at different concentrations and then their
motility was compared to that of untreated control cells.
We first wanted to assess the role of microtubular aggregation
and disaggregation in tumor cell locomotion. We employed the
drug tubulozole, which has two stereoisomeric forms: the cis
isomer which has been shown to inhibit microtubular polymer-
ization, and the trans isomer which has little effect on polymer-
ization even at 100-fold higher concentrations [14]. In A2058
cells cis-tubulozole, but not the trans stereoisomer, inhibited
AMF-stimulated motility in a concentration-dependent manner
(Fig. 1A). Treatment of the cells with 10 M cis-tubulozole
reduced the stimulated motility by at least 60%. This inhibitory
effect was partially reversible during a one hour washout
experiment (Table 1).
The pharmacologic agent, taxol, which acts by stabilizing
microtubules and promoting their polymerization, also inhibited
motility in a concentration-dependent manner (Fig. 1B). Treat-
ment of A2058 cells with 1 to 10 M taxol reduced the
stimulated motility response by at least 90%. Taxol also had a
very broad range of activity with some inhibition seen even at
concentrations as low as 0.01 sM. Unlike the other agents
tested, the taxol effect was not readily reversible (Table 1).
Both cytochalasin B and D effectively inhibited the locomo-
tive response in a concentration-dependent manner (Fig. 1C).
Cytochalasin D, which is more specific for microfilaments, was
inhibitory at lower concentrations than cytochalasin B, with




Motility after Motility after
drug drug
treatmenta washout'
% of control (SEM)C
cis-tubulazole 10.0 0.2 (0.3) 55.1 (2.6)
Taxol 5.0 7.8 (2.2) 8.2 (0.8)
Cytochalasin B 20.0 0.1 (0.4) 95.0 (5.3)
Cytochalasin D 10.0 0.0 (0.2) 82.3 (2.4)
a Cells were incubated at room temperature with the cytoskeletal
agents diluted in 0.1% BSA-DMEM for one hour, then centrifuged and
washed twice with the same agents. They were allowed an additional
30-minute incubation period prior to the start of the chemotaxis assay.
b Cells were incubated at room temperature with the cytoskeletal
agents diluted in 0.1% BSA-DMEM for one hour, then centrifuged and
washed in 0.1% BSA-DMEM. They were allowed a 30-minute recovery
period prior to the chemotaxis assay.
C Motility is expressed as a % of control which is the total motility
minus unstimulated random motility for cells treated identically but
without the addition of cytoskeletal agents. For cis-tubulozole, taxol,
and cytochalasin D, total motility was 72.3 cells/HPF and random
motility was 3.9 cells/HPF. For cytochalasin D, total motility was 64.7
cells/HPF and random motility was 3.7 cellslHPF. Stimulated motility
was measured in triplicate using AMF as chemoattractant. Random
motility was measured with 0.1% BSA-DMEM in the bottom wells.
agent, respectively. This inhibition was fully reversible (Table
1).
Effect of cytoskeletal agents on adherence
When non-ciliated cells move, they must be able to contact
and transiently adhere to the substratum. During fibroblast
locomotion, both microfilaments and microtubules have been
shown to play a role in this contact formation [3]. We wished to
determine whether the effect of the cytoskeletal agents on
A2058 motility represented primarily an inhibition of their
ability to adhere. To accomplish this, we examined the effect of
each agent on adherence to several different substrata: tissue
culture plastic to which the cells are presumed to bind in a
non-specific fashion; gelatin which is used to coat the mem-
branes in the chemotaxis assays; and laminin which is known to
bind to a high affinity receptor on the surface of these cells [22].
The adherence properties of A2058 cells which had been
preincubated for one hour with each pharmacologic agent, were
compared to those of untreated cells.
Cis-tubulozole had a profoundly inhibitory effect on adher-
ence to all of the tested substrata (Fig. 2A). Adherence to
gelatin and tissue culture plastic were most profoundly affected,
with > 90% inhibition at concentrations of 3 to 10 sM cis-
tubulozole and > 80% at 1 sM. Even at concentrations of
Fig. 1. Effect of cytoskeletal agents on AMF-stimulated motility in
A2058 cells. The cells were pretreated with varying concentrations of
the appropriate agent for one hour prior to the start of the motility assay
and kept in the same concentration of agent throughout the assay. AMF
was utilized as chemoattractant. Unstimulated random motility was
assessed with a 0.1% BSA-DMEM control for each treatment group and
was subtracted out so that the motility of each point represents
stimulated directed motility. The data are from a representative exper-
iment showing mean (of triplicate wells) SEM. A. Effects of cis (•) vs.
trans (0) stereoisomers of tubulozole on motility. B. Effect of taxol (•)
on motility. C. Effects of cytochalasin D () and cytochalasin B (0) on
motility.
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Fig. 3. Effect of preadherence on A2058 motility. The cells were
allowed to preadhere to the gelatin-coated polycarbonate membranes
for one hour prior to addition of the cytoskeletal agents to the cells in
the upper chamber or addition of chemoattractant to the lower cham-
ber. The effect of 10 iLM cis-tubulozole (A), 10 sM taxol (B), or 10 /LM
cytochalasin D (C) is shown on AMF-stimulated motility for these
pre-adherent cells (cross-hatched) vs. cells that were treated for pre-
cisely the same amount of time but not allowed to preadhere (solid).
Data are from a representative experiment showing mean (of triplicate
wells) SEM.
Fig. 2. Effect of cytoskeletal agents on adherence to different sub-
strata by A2058 melanoma cells. The cells were pretreated with varying
concentrations of cis-tubulozole (A), taxol (B), or cytochalasin D (C) for
one hour prior to the start of the adherence assay and kept in the agent
throughout the assay. Untreated cells were run concurrently as con-
trols. 50,000 cells were added to tissue culture plastic (0) or to
bacteriological wells that had been treated overnight with laminin (Lx) or
gelatin (•) as described in Methods, Adherence data are presented as a
percentage of the adherence of the untreated control cells with each
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cis-tubulozole as low as 0.1 jzM, which has little effect on
AMF-stimulated motility, adherence was significantly affected
(26.5 4.5% inhibition on gelatin dishes and 15.4 7.0% on
tissue culture plastic). Cell attachment to laminin was also
inhibited, but not as profoundly: at 10 sM cis-tubulozole, the
inhibition of adherence was only 52.0 4.6%. This effect
decreased at lower concentrations.
Taxol also affected adherence to each of the tested substrata
(Fig. 2B). As was found with cis-tubulozole, taxol had a greater
effect on cellular attachment to gelatin and tissue culture
1 o5 plastic. However, taxol generally did not completely abolish
adherence to either: at a concentration of 10 sM, adherence to
gelatin was reduced by 77.8 7.4% and adherence to tissue
culture plastic was reduced by 56.6 8.5%. As the concentra-
tion of taxol decreased, this inhibitory effect also decreased in
a linear fashion. However, taxol had only a minimal effect on
cellular attachment to laminin. Only the highest tested concen-
--i trations (1 to 10 .LM) of taxol lowered laminin adherence tolevels significantly less than those of untreated cells. Theseresults, together with those from the experiments with cis-
may be more important in the non-specific adherence of mela-
noma cells than in the receptor-mediated adherence.
tubulozole, suggest that the dynamics of tubulin polymerization
When the cells were pre-treated with cytochalasin D (Fig.
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2C), there was no significant effect on adherence to laminin.
Adherence to tissue culture plastic and gelatin-coated plates
was moderately inhibited (34.7 8.3% for tissue culture and
59.2 9.4% for gelatin). This inhibitory effect occurred prima-
rily at the highest tested concentration (10 tIM) of cytochalasin
D and fell rapidly as the concentration decreased.
Because the cytoskeletal agents all inhibited adherence to
varying degrees depending on the substratum of attachment, it
remained unclear whether their effect on motility was second-
ary to their effect on adherence. Therefore, we allowed A2058
cells to pre-adhere to the gelatin-coated polycarbonate mem-
brane used in the motility assays for one hour prior to adding an
appropriate agent to the cells in the upper chamber or adding
AMF to the lower chamber (Fig. 3). Treating pre-adherent cells
with taxol resulted in less than or equal motility compared to
non-preadhered cells (90 vs. 71% inhibition, respectively).
Treating pre-adherent cells with cis-tubulozole resulted in
slightly increased motility compared to non-preadhered cells
(69 vs. 81% inhibition, respectively). Treating pre-adherent
cells with cytochalasin D resulted in measurable but very low
motility (94% inhibition). Cytochalasin-treated cells that were
not allowed to preadhere did not move at all.
To compare the effects of the cytoskeletal agents on adher-
ence to gelatin versus motility through a gelatin-coated filter,
we ran the motility and adherence assays concurrently, using
the same cells and the same concentrations of the two agents.
Cis-tubulozole inhibited adherence more profoundly than mo-
tility at each concentration tested (Fig. 4A). In fact, it was
reproducibly found that at an intermediate concentration such
as 1 jIM, cis-tubulozole essentially abolished adherence while
the motility was only partially inhibited. In contrast, taxol (Fig.
4B) and cytochalasin D (Fig. 4C) appeared to have greater
effects on motility than on adherence. For cytochalasin D, the
two effects parallel each other with motility more profoundly
inhibited at each concentration than adherence. For taxol, the
inhibitory effect on adherence has a more shallow slope so that
adherence is affected over a broader range of concentrations,
but motility is more profoundly reduced at the highest concen-
trations.
Effect of each agent on random versus directed motility
Previous reports have indicated that microtubules are neces-
sary for cell polarization and directionality. In fact, colchicine
has been reported to inhibit primarily directional motility rather
than random motility [5]. Because AMF has both chemotactic
and chemokinetic properties [15, 161, we utilized this cytokine
to perform an abbreviated checkerboard analyses for each of
the three cytoskeletal agents. In each checkerboard (Fig. 5), the
left upper square shows background or unstimulated random
motility. The left lower square measures chemotaxis or directed
motility in a positive gradient. The right upper square shows
how the cells respond to a negative gradient. The right lower
Fig. 4. Adherence to gelatin-coated wells versus motility using gelatin-
coated membranes. A2058 cells were treated with varying concentra-
tions of cis-tubulozole (A), taxol (B), or cytochalasin D (C) for one hour
prior to the start of either assay. These cells then were either allowed to
adhere to a gelatin-coated bacteriologic plate (0) or were tested for
their capacity to locomote in response to AMF (•). The responses of
the treated cells were compared to those of concurrently run control
cells that were preindubated only in 0.1% BSA-DMEM. Data are from







































10 108 10 106
Taxol concentration, M
1 0
10 10 10 10
Cytochalasin D concentration, M
156 Stracke et a!: Cytoskeletal role in adherence/motility
square reflects cellular response in a uniform concentration of
attractant or stimulated random migration (chemokinesis). Cis-
tubulozole (Fig. SB) inhibited both chemotactic and chemoki-
netic migration by 70 to 75%. Likewise, taxol (Fig. 5C) inhibited
both motile responses by ---87%. Cytochalasin D totally abol-
ished all motility (not shown). These data indicate that there is
no preferential effect on directed or stimulated random motility
by any of the tested agents.
Discussion
We have studied how agents that act upon the cytoskeleton
affect two properties of a metastatic cell line: stimulated migra-
tion to the tumor cytokine, autocrine motility factor (AMF),
and adherence to a variety of substrata. Cis-tubulozole, taxol,
and the cytochalasins B and D all inhibited stimulated motility
in A2058 cells. The cytochalasins essentially abolished all
motility, taxol inhibited it profoundly, but cis-tubulozole had a
less uniform effect with a range of 60 to 100% inhibition. The
effect of these agents on adherence was essentially in the
opposite order of potency. Cis-tubulozole profoundly inhibited
adherence of cells to both tissue culture plastic and gelatin-
coated dishes. This effect was significant but of less magnitude
on laminin-coated dishes. Taxol similarly inhibited adherence in
the order: gelatin-coated dishes > tissue culture plastic >
laminin-coated dishes. However, in each case, the inhibition of
adherence caused by taxol was less than that caused by
cis-tubulozole. Cytochalasin D, in contrast, had no significant
effect on adherence to laminin-coated dishes and little effect on
adherence to tissue culture plastic but moderately inhibited
adherence to gelatin-coated dishes.
In neutrophils and fibroblasts, microtubules appear to be
necessary for the development of cell polarity [4, 5] and for the
formation of the focal contacts that provide traction and stabil-
ity [3]. In A2058 cells, the microtubule-specific agent cis-
tubulozole affected adherence of cells to gelatin-coated plates
more than it affected motility on gelatin-coated filters. How-
ever, the motility assays performed with pre-attached cells
indicated that cis-tubulozole significantly affected the locomo-
tive capacity of these tumor cells. Furthermore, this inhibition
was of similar magnitude for both directed and random stimu-
lation. The fact that the cells continued to locomote even when
their capacity to adhere was severely inhibited could reflect an
ability of these cells to synthesize substrate during the course of
a four hour assay or could reflect the fact that locomotion only
requires transient focal contacts with the substratum. In com-
parison, the pattern of inhibition with taxol appeared to be
Fig. 5. Effect of the cytoskeletal agents on
motility in abbreviated checkerboard assays.
Cells were preincubated for one hour in 0.1%
BSA-DMEM (A), 10 jsM cis-tubulozole (B), or
10 LM taxol (C). Half of the cells were then
tested in a routine motility assay in which
total directional motility (with AMF in the
bottom chamber) was compared to random
motility (with 0.1% BSA-DMEM in the
bottom). The second half of the cells had
AMF added directly to them. These cells
were also tested for motility when AMF
(stimulated random motility) vs. 0.1% BSA-
DMEM (negative gradient) was in the lower
chamber.
reversed: motility on gelatin substrata was affected more than
adherence. When taxol was added to pre-attached cells, motil-
ity was even more profoundly inhibited—as though the cells
were frozen in the spread out configuration and could not
squeeze through the 8 sm pores. As with cis-tubulozole, taxol
had similar inhibitory effects on both chemotaxis and chemoki-
nesis. Our data thus indicate that, like leukocytes, these tumor
cells require the dynamic association and dissociation of micro-
tubules both for stimulated motility and for attachment to
certain substrata. Unlike its effect on neutrophils, the anti-
microtubular polymerizing agent has similar effects on both
chemotaxis and chemokinesis.
Previous work with neutrophils and fibroblasts has indicated
that microfilaments are necessary to stabilize focal contacts [3,
23] and to act as a driving force in pseudopod extension and
subsequent locomotion [24—26]. In A2058 cells, the cytochala-
sins had a profound effect on stimulated motility, This occurred
even when the cells were pre-attached, although there was a
slight lessening of the otherwise total inhibition, However,
cytochalasin D had far less effect on adherence: only adherence
to gelatin was significantly inhibited. Thus, our data indicate
that microfilaments are essential for motility but less so for
adherence in these human tumor cells.
Our findings have implications for cancer therapeutic regi-
mens which include cytoskeletal agents. Colchicine, vinbias-
tine, cis-tubulozole, and taxol, all of which affect microtubules,
appear to have widespread effects on several components of the
metastatic process, including the capacity of the cells to loco-
mote and to adhere to a variety of substrata. In vivo it is
probable that adherence to basement membranes is mediated
through relatively high-affinity cell surface receptors. Our data
with laminin as substrate suggest that such adherence may be
somewhat less susceptible to these agents, but are not unaf-
fected by them. Taxol, as distinct from the other agents, was
found to be difficult to remove from these tumor cells. This
could have advantages in antineoplastic regimens; however,
because the drug also affects neutrophils [8], taxol may signif-
icantly compromise a patient's immune defenses. The revers-
ibility of taxol's effect on microtubules may be function-related
with changes in the cellular ultrastructure less readily reversible
than changes in hormone synthesis (27]. It is interesting that
agents such as the cytochalasins, which appear to affect motility
far more than adherence, have had mixed results in tests as
potential antineoplastic agents. This could be explained by the
narrower spectrum of their effects as well as by their very rapid




3 AMF 80.1±3.9 72.2±1.9
Untreated
Upper wells
B BSA AMF C BSA AMF
BSA 3.7±0.3 6.1±0.2 BSA 1.2±0.4 2.4±0.4
AMF 26.8±1.0 21.1±0.3 AMF 11.2±1.0 10.7±0.2
cls-tubulozole Taxol
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affected tumor response to a tumor-secreted motility factor.
Such a factor, with concentration correlated to metastatic
grade, has been identified in the urine of bladder cancer patients
[281.
Reprint requests to Mary L. Stracke, M.D., National Institutes of
Health, National Cancer Institute, Laboratory of Pathology, Building
10/Room 2A33, Bethesda, Maryland 20892, USA.
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